Thiethylperazine maleate, 10 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Code for Thiethylperazine maleate, 10 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen Q0174
HCPCS code Q0174 for Thiethylperazine maleate, 10 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen as maintained by CMS falls under Chemotherapy Anti-emetic Medications .
Subscribe to Codify by AAPC and get the code details in a flash.
Thiethylperazine maleate, 10 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Subscribers see the ICD-10-CM codes a contractor allows and full LCD policy text on the same website.
Protect Part B Payments by complying with Correct Coding Initiative (CCI) edits. Subscribers see the full list of column 2 codes for the searched HCPCS code.
I hope these codes work for you; this is not my area of expertise-
Q0177 Hydroxyzine pamoate, 25 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an... [ Read More ]
Carriers are quick to spot improper HCPCS code billing. Take your HCPCS Coding Compliance up a notch with related Medicare Transmittals and Manuals right at code level. Finding Medicare info can be hassle free. Time-saving HCPCS code lookup ties essential CMS documents to the HCPCS code. Add Codify's Coder Search Now!
The July update of the Ambulatory Surgical Center Payment System ASC PS implements several changes to Medicare billing instructions of which ASC coding and billing staff should be aware. The update in... [ Read More ]